Radioimmunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumor-associated antigen is used to deliver a lethal dose of radiation to the tumor cells. The ability for the antibody to specifically bind to a tumor-associated antigen increases the dose delivered to the tumor cells while decreasing the dose to normal tissues.
Related Journals of Cancer Radioimmunotherapy
Imaging and Interventional Radiology, OMICS Journal of Radiology, Radiotherapy and Oncology, Reports of Practical Oncology and Radiotherapy, Journal of Radiotherapy in Practice